Distant metastatic lesions in patients with differentiated thyroid carcinoma Clinical implications of radioiodine and FDG uptake

被引:25
|
作者
Hong, C. M. [1 ]
Ahn, B. -C. [1 ]
Jeong, S. Y. [1 ]
Lee, S. -W. [1 ]
Lee, J. [1 ]
机构
[1] Kyungpook Natl Univ, Sch Med & Hosp, Dept Nucl Med, Taegu 700721, South Korea
来源
NUKLEARMEDIZIN-NUCLEAR MEDICINE | 2013年 / 52卷 / 04期
基金
新加坡国家研究基金会;
关键词
Flip-flop phenomenon; FDG; iodine; differentiated thyroid cancer; survival; SERUM THYROGLOBULIN; EMISSION-TOMOGRAPHY; IODIDE SYMPORTER; FOLLOW-UP; CANCER; PAPILLARY; PET; DEDIFFERENTIATION; EXPRESSION; MANAGEMENT;
D O I
10.3413/Nukmed-0541-12-11
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Aim: Many investigators have reported an inverse relationship between iodine and glucose utilization of differentiated thyroid carcinoma (DTC) according to its degree of differentiation; however, not every DTC is compatible with this phenomenon. This study was conducted to evaluate the clinical implication of iodine and glucose uptake at distant metastatic lesions in DTC patients. Patients, methods: 64 DTC patients (women 47; mean age 49.9 +/- 16.4 years) with distant metastasis who underwent post I-131 treatment whole-body scan (RxWBS) and FDG PET/CT were included in the study. Radioiodine (RAI) and FDG uptake of metastatic lesions were evaluated. TSH stimulated serum thyroglobulin (s-Tg) were obtained. Results: 53 of 64 patients (82.8%) were RAI(+) group, and 37 patients (57.8%) were FDG(+) group. Patients in the RAI(-) group showed a higher rate of FDG uptake than RAI(+) group (100.0% vs. 49.1%, p = 0.002). Patients in the FDG(-) group showed a higher rate of RAI uptake than FDG(+) group (100.0% vs. 70.3%, p = 0.002). Patients with s-Tg < 100 ng/ml were frequently observed in the FDG(-)/RAI(+) group and the FDG(+)/RAI(-) group (p = 0.023). And patients with s-Tg >= 500 ng/ml were more frequently observed in the FDG(+)/RAI(+) group, compared with the FDG(+)/RAI(-) group (p = 0.036). Reduced disease-specific survival (DSS) was observed in patients with RAI(-) (p = 0.003), FDG(+) (p = 0.006), SUVmax > 3.6 (p<0.001), and s-Tg > 75.8 ng/ml (p = 0.009). In multivariate analysis, only a SUVmax > 3.6 was significantly predictive of DSS (p = 0.006). Conclusion: An inverse relationship between RAI and FDG uptake, flip-flop phenomenon, was observed in patients with metastatic lesions of DTC. Reduced disease-specific survival was observed in patients with FDG(+), RAI(-) in metastatic lesions, or high s-Tg value.
引用
收藏
页码:121 / 129
页数:9
相关论文
共 50 条
  • [1] Clinical implication of iodine or FDG uptake at distant metastatic lesion indifferentiated thyroid carcinoma patients
    Hong, C.
    Ahn, B.
    Kim, D.
    Jeong, S.
    Lee, S.
    Lee, J.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S234 - S234
  • [2] Prognostic Implications of Radioiodine Avidity and Serum Thyroglobulin in Differentiated Thyroid Carcinoma with Distant Metastasis
    Hye Jeong Kim
    Ji In Lee
    Na Kyung Kim
    Yong-Ki Min
    Sun Wook Kim
    Jae Hoon Chung
    [J]. World Journal of Surgery, 2013, 37 : 2845 - 2852
  • [3] Prognostic Implications of Radioiodine Avidity and Serum Thyroglobulin in Differentiated Thyroid Carcinoma with Distant Metastasis
    Kim, Hye Jeong
    Lee, Ji In
    Kim, Na Kyung
    Min, Yong-Ki
    Kim, Sun Wook
    Chung, Jae Hoon
    [J]. WORLD JOURNAL OF SURGERY, 2013, 37 (12) : 2845 - 2852
  • [4] Radioiodine therapy of metastatic lesions of differentiated thyroid cancer
    Luster, M.
    Haenscheid, H.
    Freudenberg, L. S.
    Verburg, F. A.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2012, 35 (06) : 21 - 29
  • [5] Radioiodine (131I) uptake in distant Metastases as a predicting factor of survival in differentiated thyroid carcinoma patients
    Mihailovic, J.
    Stefanovic, L.
    Malesevic, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S231 - S231
  • [6] OUTCOME OF 309 PATIENTS WITH METASTATIC DIFFERENTIATED THYROID-CARCINOMA TREATED WITH RADIOIODINE
    PACINI, F
    CETANI, F
    MICCOLI, P
    MANCUSI, F
    CECCARELLI, C
    LIPPI, F
    MARTINO, E
    PINCHERA, A
    [J]. WORLD JOURNAL OF SURGERY, 1994, 18 (04) : 600 - 604
  • [7] METASTATIC FOLLICULAR CARCINOMA OF THE THYROID - REAPPEARANCE OF RADIOIODINE UPTAKE
    OYEN, WJG
    MUDDE, AH
    VANDENBROEK, WJM
    CORSTENS, FHM
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1995, 36 (04): : 613 - 615
  • [8] Metastatic differentiated thyroid carcinoma: clinical management and outcome of disease in patients with initial and late distant metastases
    Mihailovic, Jasna M.
    Stefanovic, Ljubomir J.
    Malesevic, Milica D.
    Erak, Marko D.
    Tesanovic, Dusanka D.
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2009, 30 (07) : 558 - 564
  • [9] Influence of thyroid-stimulating hormone levels on uptake of FDG in recurrent and metastatic differentiated thyroid carcinoma
    Moog, F
    Linke, R
    Manthey, N
    Tiling, R
    Knesewitsch, P
    Tatsch, K
    Hahn, K
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (12): : 1989 - 1995
  • [10] Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma
    Hoftijzer, Hendrieke
    Heemstra, Karen A.
    Morreau, Hans
    Stokkel, Marcel P.
    Corssmit, Eleonora P.
    Gelderblom, Hans
    Weijers, Karin
    Pereira, Alberto M.
    Huijberts, Maya
    Kapiteijn, Ellen
    Romijn, Johannes A.
    Smit, Johannes W.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2009, 161 (06) : 923 - 931